WEST PALM BEACH, FL / ACCESSWIRE / November 21, 2017 / Alliance BioEnergy Plus, Inc. (“ALLM“) (OTCQB: ALLM) (the “Company”) today announced that it has filed its fifteenth patent application, this time focusing on the design of its commercial scale CTS reactors. With four issued patents and now fifteen filed and pending patents, the protection surrounding the CTS process is becoming more and more formidable. As the Company prepares to launch its CTS process commercially, the protection of its intellectual propertyRead more
- Research on Lodonal for HIV related GI complications featured in Plus Magazine
- Cannabis Strategic Ventures and Sunniva Inc. Enter Into Cannabis Extraction Services Agreement
- Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies
- Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System
- PHI Group Partners with Fintech Green Investment Company
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More